INHIBRX BIOSCIENCES, INC. (INBX) Operating cash flow 2023–2025
INHIBRX BIOSCIENCES, INC. (INBX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$129.8MFY2025 · since FY2023: -$193.3M → -$129.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$129.8M | +33.2% |
| FY2024 | -$194.4M | -0.6% |
| FY2023 | -$193.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice